Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Stereotactic Radiation Therapy In Centrally Located Lung and Ultra-centrally Located Tumors in the Lung. STRICT-LUNG & STAR-LUNG STUDY

NCT05354596 is registered in ClinicalTrials.gov with Rigshospitalet, Denmark as lead sponsor.

NCT NCT05354596
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05354596 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Stereotactic Radiation Therapy In Centrally Located Lung and Ultra-centrally Located Tumors in the Lung. STRICT-LUNG & STAR-LUNG STUDY
Lead sponsor
Rigshospitalet, Denmark
Phase
Not applicable
Overall status
Recruiting
Start date
November 1, 2022
Completion date
May 1, 2033
Enrollment
138 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer, metastases to lung, radiotherapy side effect